Articles

Treasury yields touched their lowest levels in more than two months following Wednesday’s cooler than expected CPI print, bringing them to the upper bound of what analysts at Renaissance Macro deemed “the soft landing zone.”

Shares of Sarepta Therapeutics climbed early Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial.

They signed up to earn their graduate degrees with promises they could complete school quickly and affordably. But they wound up mired in extra courses and on the hook for thousands of dollars more than they were told.

U.S. wholesale prices fell in May for the second time in three months, potentially another sign that an upturn in inflation earlier this year is fading.

Claims up 13,000 to 242,000 versus 225,000 forecast

GameStop Corp. shares rallied 3.9% in premarket trades Thursday ahead of the videogame retailer’s annual shareholder meeting, which is scheduled for 11 a.m. Eastern Time.

A breakthrough will help treatment and drug trials, scientists say.

Adults aged 18 and older enjoyed higher efficacy in a late-stage trial of Moderna’s next-gen vaccine than the original one.

Some financial advisers are trying to help clients with the nonfinancial aspects of retirement

The stock is up 14% in premarket action, putting the company on pace to add $100 billion in market cap if that rally holds through Thursday’s close.

3M said Thursday it will transfer about $2.5 billion of its pension-payment obligations to Met Tower Life.

Lead tech analyst at the I/O Fund, Beth Kindig, who has made some prescient calls, says Nvidia can be beat in the long run.